Home
Global Protein Summit
7 June - 8 June 2006
Global Protein Summit

With the ever-expanding therapeutic market, research and development is fundamental for improving current treatments and the design of protein based drugs of the future. With the variety of protein expression systems rapidly evolving, there is more pressure to harvest larger, purer quantities of product. Furthermore, a vast number of biomarker discovery studies have recently been embarked upon, requiring new, more efficient methods to identify and analyse proteins involved in disease populations with the aim to lead to novel diagnostic tools and treatments.

SAE Media Group’s Global Protein Summit, 2006 will be an excellent opportunity to hear about the latest developments from world leaders, bringing together expertise in effective protein expression, purification, identification and functional analysis and how to overcome the common and not so common pitfalls. Discussing research and manufacturing activities in both academia and industry, this unique opportunity will provide genuine opportunities of networking. A must attend event for all those involved in protein research and production.

Hear contributions from leading industry experts, including:

  • Dr Scott Patterson, Senior Director, Medical Sciences, Amgen Inc
  • Dr Zhijian Lu, Assistant Director, Biotherapeutics Expression & Purification, Wyeth
  • Dr Stephen Irving, Senior Principal Scientist, Pfizer
  • Dr Joey M. Studts, Principal Scientist & Head, Protein Resources, Boehringer-Ingelheim
  • Dr Thierry Battle, Biotechnology Services Manager, Serono Pharmaceutical Research Institute
  • Dr Tauseef Butt, President, Life Sensors
  • Dr Robert Wynands, Director, Structural Biology, Takeda San Diego
  • Dr Alex Breeze, Head, NMR Structural Biology, AstraZeneca
  • Dr Michael Dyson, Project Leader, Protein Expression, The Wellcome Trust Sanger Institute

Conference agenda

clock

8:30

Registration & Coffee

clock

9:00

Welcome and Introductions

An opportunity to meet and discuss challenges

clock

9:20

Bacterial protein expression

  • Engineering and expression optimisation
  • Bottleneck identification and limitations
  • Considerations for use as a target or a product
  • clock

    10:00

    Mammalian cell expression (biotherapeutic production)

  • Cell line/vector combinations
  • Establishing a production cell line (master/working cell banks)
  • Productivity, stability and scale
  • clock

    10:40

    Morning Coffee

    clock

    11:10

    Mammalian cell expression (screening)

  • Vectors, promoter and tags and cell lines
  • Establishing cell lines for GPCR and Kinase screening
  • Cell lines for HCS, what do they tell us?
  • clock

    11:50

    Novel technology

  • Baculovirus, 48 hours to express active proteins in insect cells
  • Reverse proteomics platforms
  • Automated expression
  • clock

    12:10

    Discussion & questions – review of the session

    clock

    12:30

    Close of Executive Briefing

    clock

    13:30

    Registration & Coffee

    clock

    14:00

    Welcome and Introductions

    An opportunity to meet and discuss challenges

    clock

    14:20

    Domains are the route to new drug targets

  • The precedent from structural biology
  • Current methods of drug discovery and optimisation
  • Vaccines and super-vaccines: a multi-domain approach
  • clock

    15:00

    Hsp90 and chaperones

  • Defining the target: biology, bioinformatics and domain prediction
  • Domain discovery to drugs via structural biology
  • A pathway in fragments, Hsp90 complexes and future drug discovery
  • clock

    15:40

    Afternoon Tea

    clock

    16:10

    Fast-track empirical domain delimitation

  • p85: 5 domains in 12 years to domains and combinations in 6 months
  • Building a high through put domain-discovery pipeline
  • Domains in complexes, a new proof of principle
  • clock

    16:50

    Application of domain technology to whole organisms

  • Multiple targets for vaccine discovery
  • New vaccines with multiple properties from domain discovery
  • clock

    17:10

    Discussion and questions – review of the session

    clock

    17:30

    Close of Executive Briefing

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    Tauseef Butt

    Tauseef Butt, President, Life Sensors

    clock

    9:10

    MOVING PROTEIN DRUG CANDIDATES FROM DISCOVERY TO DEVELOPMENT

    Zhijian Lu

    Zhijian Lu, Assistant Director, Biotherapeutics Expression & Purification, Wyeth Research

  • The biotech heritage of Wyeth
  • Different forms of recombinant protein drugs
  • Protein expression in E. coli, thioredoxin fusion system
  • CHO cell expression system
  • Process improvement
  • clock

    9:50

    SUMO TAGS AND DIFFICULT TO EXPRESS PROTEINS

    Tauseef Butt

    Tauseef Butt, President, Life Sensors

  • SUMOylation system, nature’s design for tagging and chaperoning proteins in cells
  • SUMO family of tags remarkably enhance protein expression and facilitate purification
  • No parallel system for producing proteins with desired N-termini
  • Chaperone properties of SUMO system to produce native structures
  • Designer tags for solubilisation of challenging proteins
  • clock

    10:30

    Morning Coffee

    clock

    11:30

    INSECT CELL EXPRESSION SYSTEMS

    Joey Studts

    Joey Studts, Principal Scientist & Head, Protein Resources, Boehringer Ingelheim

  • Baculovirus instead of E.coli expression as first line trials for structural research support
  • Elimination of cloning bottleneck using gene synthesis collaboration
  • Multi-paralleled expression screening of constructs on an E.coli timescale
  • 4 days form DNA to expression results
  • 21 days from DNA to Biomass, including plaque purification
  • Reproducible scale-up without the use of viral titres
  • clock

    12:10

    A SIMPLE TECHNOLOGY FOR THE SIMULTANEOUS EXPRESSION OF 4 TANDEM GENES

    Jon Chestnut

    Jon Chestnut, Research & Development, Invitrogen Ltd

  • Expression of multiple proteins from one promoter or multiple proteins with different promoters
  • Protein expressed at desired levels in the same cell
  • Eliminating the need for co-transfection of multiple plasmids
  • Expression of 1-4 different inserts from one vector
  • Ultimate flexibility: removal and replacement of single or multiple inserts from a construct
  • clock

    12:50

    Networking Lunch

    clock

    14:20

    HIGH-THROUGHPUT PROTEIN PRODUCTION SYSTEM AT SMALL / INTERMEDIATE SCALE

    Thierry Battle

    Thierry Battle, Biotechnology Services Manager, Serono Pharmaceutical Research Institute

  • Summary of general pipeline system and mechanistics
  • Lessons learned
  • A discussion of issues regarding tech-transfer
  • clock

    15:00

    BACULOVIRUS PRODUCTION AND PROTEIN EXPRESSION

    Kevin Richards

    Kevin Richards, Senior scientist, NextGen Sciences Ltd

  • An overview of traditional methods
  • New technologies to overcome the labour intensive and technically demanding nature of baculovirus production and protein expression
  • Development of the baculoworkstation
  • Manual vs automated procedures
  • The advantages of the baculoworkstation
  • clock

    15:40

    Afternoon Tea

    clock

    16:00

    PRODUCTION OF SOLUBLE MAMMALIAN PROTEINS IN ESCHERICHIA COLI

    Michael Dyson

    Michael Dyson, Project Leader, Protein Expression, Wellcome Trust Sanger Institute

  • Cloning strategy
  • Comparison of tags and host strains for E. coli expression
  • Production pipeline to supply antigens for antibody production
  • A case study: the immunoglobulin superfamily (IgSF)
  • clock

    16:40

    HIGH THROUGHPUT VALUATION OF PROTEIN EXPRESSION CLONES

    Konrad Bussow

    Konrad Bussow, Team Leader, Protein Structure Factory, Max Planck Institute for Molecular Genetics

  • E. coli protein expression and protein purification in microtitre plates
  • Comparison of micro-scale and large-scale protein production for crystallisation and structural analysis
  • Data management of large numbers of clones
  • clock

    17:20

    Chairman’s Closing Remarks and Close of Day One

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    Scott Patterson

    Scott Patterson, Senior director, Medical Sciences, Amgen

    clock

    9:10

    BIOMARKERS – THE NEW AGE OF DIAGNOSTICS AND DRUG DISCOVERY?

    Scott Patterson

    Scott Patterson, Senior director, Medical Sciences, Amgen

  • Identifying the unmet medical need
  • Techniques and tools
  • New developments
  • Potential pitfalls in biomarker analysis
  • clock

    9:50

    PROTEIN PROCESSING

    Paul Docherty

    Paul Docherty, Buiness Development, Novexin

  • Greater protein stability
  • Minimise losses during purification
  • Obtain full structural data without interference with the protein
  • Simpler protein refolding
  • Better protein assays and analysis
  • clock

    10:30

    Morning Coffee

    clock

    10:55

    HIGH THROUGHPUT PROTEIN PURIFICATION

    David Bannister

    David Bannister, Senior Protein Purification Scientist, Cambridge Antibody Technology

  • Overview of high throughput protein purification methods and hardware
  • Purity vs yield
  • Time and cost implications
  • The future of protein purification
  • clock

    11:30

    PROTEIN PURIFICATION AND CRYSTALLISATION SUCCESS RATES

    Robert  Wynands

    Robert Wynands, Director, Structural Biology, Takeda San Diego, Inc

  • High throughput protein purification methods used to produce proteins for crystallisation trials
  • Analytical methods used in-process and for end products
  • Nanovolume Crystallisation®
  • The use of databases for tracking
  • Examples
  • Lessons learnt

  • clock

    12:40

    Networking Lunch

    clock

    13:40

    STRATEGIES FOR SUPPLYING PROTEINS FOR STRUCTURAL STUDIES

    Stephen Irving

    Stephen Irving, Senior Principal Scientist, Pfizer

  • Protein production – overcoming challenges
  • Experiences with alternative expression systems
  • Protein purification and affinity tags
  • Mutagenisis strategies
  • Case studies
  • clock

    14:20

    PROTEIN REFOLDING

    Stefan Schmidt

    Stefan Schmidt, Team Leader, Protein Science, AstraZeneca

  • Current strategies
  • Optimising conditions
  • Automated and parallel approaches
  • Functional analysis
  • Challenges and future perspectives
  • clock

    15:00

    THE NEXT FRONTIER IN PROTEIN ANALYSIS

    Bahram Fathollahi

    Bahram Fathollahi, Research & Development Engineer, Microfluidics, Caliper Life Sciences

  • Time to result and quantitative data are vital in protein process decisions
  • Quality of decisions are based on quality of data
  • Microfluidic assays are the new SDS-PAGE
  • Automated analysis is key to data reproducibility and laboratory throughput
  • clock

    15:40

    Afternoon Tea

    clock

    16:40

    FRAGMENT-BASED DRUG DISCOVERY

    Alex  Breeze

    Alex Breeze, Head, NMR Structural Biology, AstraZeneca

  • Why screen fragments?
  • NMR-based approaches for fragment library screening
  • Challenges for crystallography of fragment hits
  • Building leads from fragments
  • Embedding fragment-based approaches into the big pharma environment
  • Case studies from AstraZeneca
  • clock

    17:20

    Chairman’s Closing Remarks and Close of Day One

    Workshops

    Protein Expression Technologies

    Protein Expression Technologies

    Holiday Inn Bloomsbury
    9 June 2006
    London, United Kingdom

    Domains: Drug Targets & Vaccines

    Domains: Drug Targets & Vaccines

    Holiday Inn Bloomsbury
    9 June 2006
    London, United Kingdom

    Holiday Inn Bloomsbury

    Coram Street
    London WC1N 1HT
    United Kingdom

    Holiday Inn Bloomsbury

    Holiday Inn London-Bloomsbury is just 2 minutes' walk from the Tube at Russell Square station, for speedy connections across the capital. We're 10 minutes by bus from Eurostar connections at St Pancras station, and a 45-minute taxi ride from London Heathrow Airport. Check into your stylish Guest room, air-conditioned and connected to wireless Internet.

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.